There are well-established disparities in cancer incidence and outcomes by race/ethnicity
that result from the interplay between structural, socioeconomic, socio-environmental …

Liquid biopsy can detect circulating cancer cells or tumor cell-derived DNA at various stages
of cancer. The fluid from these biopsies contains extracellular vesicles (EVs), such as …

The global breast cancer burden is growing. Of 19.3 million new cancers diagnosed in 2020,
2.26 million were breast, surpassing lung as the most commonly diagnosed worldwide …

PURPOSE: We sought to examine tumor subtype, stage at diagnosis, time to surgery (TTS),
and overall survival (OS) among Hispanic patients of different races and among Hispanic …

Abstract The Hispanic/Latino (x) population (H/L) in the United States of America is
heterogeneous and fast growing. Cancer is the number one cause of death among H/Ls …

Somatic mutational profiling is increasingly being used to identify potential targets for breast
cancer. However, limited tumor-sequencing data from Hispanic/Latinas (H/L) are available …

Introduction Breast cancer is a heterogeneous disease, and the distribution of the different
subtypes varies by race/ethnic category in the United States and by country. Established …

Abstract Background The BRCA1 c. 3331_3334delCAAG founder mutation has been
reported in hereditary breast and ovarian cancer families from multiple Hispanic groups. We …

Aggressive breast cancers portend a poor prognosis, but current polygenic risk scores
(PRSs) for breast cancer do not reliably predict aggressive cancers. Aggressiveness can be …

Abstract Purpose of Review Breast cancer incidence and mortality rates are lower in some
Hispanic/Latino subpopulations compared with non-Hispanic White women. However …